Suparna Wedam, Preeti Narayan, Haley Gittleman, Joyce Cheng, Vishal Bhatnagar, Hairat Sabit, Lauren S.L. Price, Nam Atiqur Rahman, Haw-Jyh Chiu, Nikolett Biel, Tiffany Ricks, Mallorie Fiero, Shenghui Tang, Christy Osgood, William Pierce, Richard Pazdur, Paul G. Kluetz, Laleh Amiri-Kordestani. "US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant,
            <i>PIK3CA</i>
            -Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, Locally Advanced or Metastatic Breast Cancer." Journal of Clinical Oncology, 2025. doi:10.1200/jco-25-00663